—
C+
C+ The full Closelooknet — membership. Open the C+ overview

McKesson Corporation (MCK) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for MCK, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.30 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How MCK has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.30 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), McKesson Corporation moved 0.30% on average · correlation 0.09 · higher than 30% of US names
  • Beta, last 3 months 0.23 about the same as over the year
  • On the 10 worst bond days −0.67% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.27% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Distribution · United States · 3 names with week and year-to-date

Peer group

Medical Distribution · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against MCK on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — McKesson Corporation

MCK in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
McKesson distributes pharmaceutical drugs and healthcare products across four segments: North American pharmaceutical distribution, oncology and multispecialty, prescription technology solutions, and medical-surgical supplies. It delivers medicines and supplies to pharmacies, hospitals, clinics and long-term care centres, and provides logistics support to drug manufacturers. It also runs technology services that handle prescription pricing checks, benefit verification and patient enrolment for pharmacies and health plans. The company is based in Irving, Texas, and lists on a US exchange.
Where it sits in the stack
McKesson sits outside the AI build-out coverage the diary tracks in our index; it belongs to the healthcare sector, within medical distribution, moving drugs and medical supplies rather than compute or components.
Who it is priced against
Closelooknet's peer group for McKesson has not been set in the diary; the market usually compares it with Cencora and Cardinal Health, the other large US drug wholesalers.
Why Closelooknet tracks it
McKesson holds a seat in the S&P 500 within our index coverage. It carries no seat in our AI build-out index and no Closelooknet score yet, and the diary has not quoted it in an edition so far.
What the diary watches
The diary watches whether McKesson's technology and specialty-drug segments grow enough to offset the thin margins of its core wholesale distribution business.

McKesson Corporation (MCK) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.39%, quarterly · last 0.94 USD on 2026-09-01

Dividends and capital return

What MCK pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 3.40 USD per share · a 0.39% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +15.5% against the prior twelve months prior twelve months 2.94 USD per share
  • Last distribution 0.94 USD per share as the price series records it, within days of the ex-date 2026-09-01
  • By calendar year 2023: 0.62 USD (partial) · 2024: 2.66 USD · 2025: 3.05 USD · 2026: 2.58 USD to date first distribution recorded in the three-year window: 2023-11-30

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is McKesson Corporation (MCK)?

McKesson Corporation trades as MCK on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is MCK in a Closelooknet index?

Not currently — McKesson Corporation is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does MCK trade against its moving averages?

Pullback inside an uptrend stack: Trades -0.8% vs the 50-day and +2.6% vs the 200-day average, 13.2% below the 52-week high and +21.5% off the 52-week low; a golden cross printed 16 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does McKesson Corporation trade when bond yields rise?

Over the past year McKesson Corporation had a beta of 0.30 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 30% of US names. On the 10 sessions in which long bonds fell most it moved −0.67% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What does McKesson Corporation do?

McKesson distributes pharmaceutical drugs and healthcare products across four segments: North American pharmaceutical distribution, oncology and multispecialty, prescription technology solutions, and medical-surgical supplies. It delivers medicines and supplies to pharmacies, hospitals, clinics and long-term care centres, and provides logistics support to drug manufacturers. It also runs technology services that handle prescription pricing checks, benefit verification and patient enrolment for pharmacies and health plans. Closelooknet's peer group for McKesson has not been set in the diary; the market usually compares it with Cencora and Cardinal Health, the other large US drug wholesalers.

Where does McKesson Corporation sit in the AI build-out?

McKesson sits outside the AI build-out coverage the diary tracks in our index; it belongs to the healthcare sector, within medical distribution, moving drugs and medical supplies rather than compute or components. McKesson holds a seat in the S&P 500 within our index coverage. It carries no seat in our AI build-out index and no Closelooknet score yet, and the diary has not quoted it in an edition so far.

Does McKesson Corporation pay a dividend?

McKesson Corporation has paid 3.40 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.39% on the 2026-09-25 close; the last distribution recorded in the price series was 0.94 USD on 2026-09-01. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for MCK, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.